Corrigendum to "Clinical trial designs for evaluating and exploiting cancer evolution" [Cancer Treat. Rev. 118 (2023) 101583].

Ingles Garces, Alvaro H; Porta, Nuria; Graham, Trevor A; Banerji, Udai

Ingles Garces, Alvaro H; Porta, Nuria; Graham, Trevor A; Banerji, Udai.

Afiliación

Ingles Garces AH; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, UK.
Porta N; Clinical Trials and Statistical Unit, The Institute of Cancer Research, UK.
Graham TA; Centre for Evolution and Cancer, The Institute of Cancer Research, UK.
Banerji U; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, UK. Electronic address: Udai.Banerji@icr.ac.uk.

Cancer Treat Rev ; 119: 102596, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37419039

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Treat Rev Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido